Mylan Calls Allergan's Patent Sale to Tribe a 'Sham'

Generic-drug company Mylan has fired back at rival Allergan’s attempt to shield its top-selling eye medication from competition by transferring the patents to an Indian tribe.

from WSJ.com: US Business http://ift.tt/2gcmpJ0
via IFTTT